Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hyperandrogenism × Spironolactone × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 2 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2 Neoplasms 2 Obesity 1 Leukemia, Myeloid, Acute 1 Hyperandrogenism 1 Heart Failure 1 Critical Illness 1 Cardiotoxicity 1 Acute Kidney Injury 1

Interventions

Metformin 2 drospirenone and ethinyl estradiol combination 1 bicalutamide 1 Ultrasonography 1 Topiramate 1 Spironolactone 1 Progesterone 1 Ovidrel 1 Hematologic Tests 1 Ethinyl Estradiol 1 Dexamethasone 1 Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04075149 2023-10-27

CBS009

University of Virginia

Phase EARLY_PHASE1 Unknown

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡